相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。MYC as a Multifaceted Regulator of Tumor Microenvironment Leading to Metastasis
Erna Marija Meskyte et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
High expression of MKK3 is associated with worse clinical outcomes in African American breast cancer patients
Xuan Yang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2020)
c-MYC Drives Breast Cancer Metastasis to the Brain, but Promotes Synthetic Lethality with TRAIL
Ho Yeon Lee et al.
MOLECULAR CANCER RESEARCH (2019)
MKK3 modulates JNK-dependent cell migration and invasion
Yihao Sun et al.
CELL DEATH & DISEASE (2019)
Development of a Time-Resolved Fluorescence Resonance Energy Transfer Ultrahigh-Throughput Screening Assay for Targeting the NSD3 and MYC Interaction
Jinglin Xiong et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2018)
Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas
Franz X. Schaub et al.
CELL SYSTEMS (2018)
Targeting oncogenic Myc as a strategy for cancer treatment
Hui Chen et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2018)
AKT1, LKB1, and YAP1 Revealed as MYC Interactors with NanoLuc-Based Protein-Fragment Complementation Assay
Xiulei Mo et al.
MOLECULAR PHARMACOLOGY (2017)
OncoPPi-informed discovery of mitogen-activated protein kinase kinase 3 as a novel binding partner of c-Myc
A. A. Ivanov et al.
ONCOGENE (2017)
The OncoPPi network of cancer-focused protein-protein interactions to inform biological insights and therapeutic strategies
Zenggang Li et al.
NATURE COMMUNICATIONS (2017)
Strategies to Inhibit Myc and Their Clinical Applicability
Jonathan R. Whitfield et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2017)
Family matters: How MYC family oncogenes impact small cell lung cancer
Johannes Braegelmann et al.
CELL CYCLE (2017)
MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition
Gurkan Mollaoglu et al.
CANCER CELL (2017)
Recurrent amplification of MYC and TNFRSF11B in 8q24 is associated with poor survival in patients with gastric cancer
Xiaohong Wang et al.
GASTRIC CANCER (2016)
Targeting MKK3 as a novel anticancer strategy: molecular mechanisms and therapeutical implications
S. Baldari et al.
CELL DEATH & DISEASE (2015)
New Insights on the Mechanism of Quinoline-based DNA Methyltransferase Inhibitors
Christina Gros et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
c-Myc suppresses microRNA-29b to promote tumor aggressiveness and poor outcomes in non-small cell lung cancer by targeting FHIT
D-W Wu et al.
ONCOGENE (2015)
Clinicopathologic and prognostic significance of c-MYC copy number gain in lung adenocarcinomas
A. N. Seo et al.
BRITISH JOURNAL OF CANCER (2014)
MYC amplification is associated with poor survival in small cell lung cancer: a chromogenic in situ hybridization study
Rita de Cassia S. Alves et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2014)
Improving Docking Results via Reranking of Ensembles of Ligand Poses in Multiple X-ray Protein Conformations with MM-GBSA
P. A. Greenidge et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2014)
Selective Non-nucleoside Inhibitors of Human DNA Methyltransferases Active in Cancer Including in Cancer Stem Cells
Sergio Valente et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
A role for mitogen kinase kinase 3 in pulmonary inflammation validated from a proteomic approach
T. Holand et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2014)
MYC Activation Is a Hallmark of Cancer Initiation and Maintenance
Meital Gabay et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2014)
Synthetic approaches to DNMT inhibitor SGI-1027 and effects on the U937 leukemia cell line
Patricia Garcia-Dominguez et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
MAPK Kinase 3 Potentiates Chlamydia HSP60-Induced Inflammatory Response through Distinct Activation of NF-κB
Yanhua Kang et al.
JOURNAL OF IMMUNOLOGY (2013)
MYC Amplification as a Prognostic Marker of Early-Stage Lung Adenocarcinoma Identified by Whole Genome Copy Number Analysis
Reika Iwakawa et al.
CLINICAL CANCER RESEARCH (2011)
Activation and Function of the MAPKs and Their Substrates, the MAPK-Activated Protein Kinases
Marie Cargnello et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2011)
A New Class of Quinoline-Based DNA Hypomethylating Agents Reactivates Tumor Suppressor Genes by Blocking DNA Methyltransferase 1 Activity and Inducing Its Degradation
Jharna Datta et al.
CANCER RESEARCH (2009)
Serial analysis of chromatin occupancy identifies β-catenin target genes in colorectal carcinoma cells
Gregory S. Yochum et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes
Richard A. Friesner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Mitogen-activated protein kinase kinase 3 is a pivotal pathway regulating p38 activation in inflammatory arthritis
T Inoue et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Epigenetic reactivation of tumor suppressor genes by a novel small-molecule inhibitor of human DNA methyltransferases
B Brueckner et al.
CANCER RESEARCH (2005)
The biology of p38 kinase: A central role in inflammation
GL Schieven
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2005)
The life cycle of C-myc - From synthesis to degradation
RC Sears
CELL CYCLE (2004)
Opinion - Analysis of genomic targets reveals complex functions of MYC
JH Patel et al.
NATURE REVIEWS CANCER (2004)
Phosphorylation by glycogen synthase kinase-3 controls c-Myc proteolysis and subnuclear localization
MA Gregory et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
X-ray structures of Myc-Max and Mad-Max recognizing DNA: Molecular bases of regulation by proto-oncogenic transcription factors
SK Nair et al.
CELL (2003)
Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability
R Sears et al.
GENES & DEVELOPMENT (2000)
分享论文
